Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2021
Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck CancerRamachandra Katabathula, Peronne Joseph, Salendra Singh, et al.
Leukemia & Lymphoma|September 6, 2023
Baseline correlates of frailty and its association with survival in United States veterans with acute myeloid leukemiaJennifer La, Michelle H Lee, Mary T Brophy, et al.
Virology|May 16, 2009
Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancyJanet L Brandsma, Ying Sun, Paul M Lizardi, et al.
Cancer Medicine|March 26, 2022
Prognostic value of the veterans affairs frailty index in older patients with non-small cell lung cancerDavid Cheng, Clark Dumontier, Ayesha R Sheikh, et al.
Molecular Cancer Research : MCR|September 14, 2016
Estrogen Drives Cellular Transformation and Mutagenesis in Cells Expressing the Breast Cancer-Associated R438W DNA Polymerase Lambda ProteinAntonia A Nemec, Korie B Bush, Jamie B Towle-Weicksel, et al.
Journal of the National Cancer Institute|October 8, 2020
Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs StudyNathanael R Fillmore, Jennifer La, Raphael E Szalat, et al.
Plos One|November 22, 2013
Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapyRobert Lindner, Catherine Sullivan, Onyinye Offor, et al.
Breast Cancer Research and Treatment|September 15, 2012
Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancerVeronique M Neumeister, Catherine A Sullivan, Robert Lindner, et al.
JCO Clinical Cancer Informatics|May 10, 2024
Phenotyping Hepatic Immune-Related Adverse Events in the Setting of Immune Checkpoint Inhibitor TherapyTheodore C Feldman, David E Kaplan, Albert Lin, et al.
Molecular Cancer Therapeutics|December 17, 2016
Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent CancersKaiming Sun, Ruzanna Atoyan, Mylissa A Borek, et al.
Pageof 3